Pegylated Interferon and Ribavirin in Hepatitis C Virus Infection After Liver Transplantation.
Status:
Completed
Trial end date:
2006-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to evaluate the efficacy (and safety) of antiviral therapy in
patients with chronic hepatitis C after liver transplantation. The only approved drugs for
treatment of hepatitis C are pegylated interferon and ribavirin.